TY  - GEN
AU  - Chlebowski,R T
AU  - Collyar,D E
AU  - Somerfield,M R
AU  - Pfister,D G
TI  - American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene
SN  - 0732-183X
PY  - 2000///0113
KW  - Anticarcinogenic Agents
KW  - adverse effects
KW  - Bone Density
KW  - drug effects
KW  - Breast Neoplasms
KW  - epidemiology
KW  - Cardiovascular Diseases
KW  - Cataract
KW  - Endometrial Neoplasms
KW  - chemically induced
KW  - Estrogen Antagonists
KW  - Expert Testimony
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Menopause
KW  - Raloxifene Hydrochloride
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Tamoxifen
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1200/JCO.1999.17.6.1939
ER  -